Literature DB >> 23188565

Update on the performance and application of basophil activation tests.

Emily C McGowan1, Sarbjit Saini.   

Abstract

The basophil activation test (BAT) is a flow-cytometry-based functional assay that assesses the degree of cell activation after exposure to a stimuli. Though no standardized technique currently exists, recent advances have improved the performance of this assay, including identification of new basophil-specific markers and comparisons of the expression of CD63 to CD203c during activation. The basophil activation test has also been validated for many IgE-mediated disease conditions, which have been extensively reviewed elsewhere. This review focuses on the most recent applications of this test to the diagnosis of allergy to drugs, foods, venoms, and pollens, and the evolving role of the BAT in monitoring immunotherapy.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23188565      PMCID： PMC4078398          DOI： 10.1007/s11882-012-0324-x

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.806


  78 in total

1.  Basophil activation test in the diagnosis of sulphite-induced immediate urticaria.

Authors:  P García-Ortega; E Scorza; A Teniente
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

2.  Marked differences in the signaling requirements for expression of CD203c and CD11b versus CD63 expression and histamine release in human basophils.

Authors:  Donald MacGlashan
Journal:  Int Arch Allergy Immunol       Date:  2012-06-20       Impact factor: 2.749

3.  Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation.

Authors:  A G Togias; R M Naclerio; J Warner; D Proud; A Kagey-Sobotka; I Nimmagadda; P S Norman; L M Lichtenstein
Journal:  JAMA       Date:  1986-01-10       Impact factor: 56.272

4.  Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.

Authors:  L Van Overtvelt; V Baron-Bodo; S Horiot; H Moussu; C Ricarte; F Horak; P Zieglmayer; R Zieglmayer; A Montagut; S Galvain; O de Beaumont; M Le Gall; P Moingeon
Journal:  Allergy       Date:  2011-08-29       Impact factor: 13.146

5.  Monitoring honeybee venom immunotherapy in children with the basophil activation test.

Authors:  Simona E K Žitnik; Tina Vesel; Tadej Avčin; Mira Šilar; Mitja Košnik; Peter Korošec
Journal:  Pediatr Allergy Immunol       Date:  2011-12-04       Impact factor: 6.377

6.  The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media.

Authors:  Panwas Pinnobphun; Supranee Buranapraditkun; Thatchai Kampitak; Nattiya Hirankarn; Jettanong Klaewsongkram
Journal:  Ann Allergy Asthma Immunol       Date:  2011-02-05       Impact factor: 6.347

7.  The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting.

Authors:  P Bonadonna; R Zanotti; G Melioli; F Antonini; I Romano; L Lenzi; B Caruso; G Passalacqua
Journal:  Allergy       Date:  2012-07       Impact factor: 13.146

8.  A new variant of the basophil activation test for allergen-induced basophil CD63 upregulation. The effect of cetirizine.

Authors:  A Wolanczyk-Medrala; G Gogolewski; J Liebhart; K Gomulka; M Litwa; B Panaszek; K Lindner; W Medrala
Journal:  J Investig Allergol Clin Immunol       Date:  2009       Impact factor: 4.333

9.  Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results.

Authors:  P Korosec; R Erzen; M Silar; N Bajrovic; P Kopac; M Kosnik
Journal:  Clin Exp Allergy       Date:  2009-08-18       Impact factor: 5.018

10.  Basophil activation tests for the diagnosis of food allergy in children.

Authors:  A Ocmant; S Mulier; L Hanssens; M Goldman; G Casimir; F Mascart; L Schandené
Journal:  Clin Exp Allergy       Date:  2009-06-22       Impact factor: 5.018
View more
  34 in total

1.  Chlorhexidine allergy in four specialist allergy centres in the United Kingdom, 2009-13: clinical features and diagnostic tests.

Authors:  W Egner; M Helbert; R Sargur; K Swallow; N Harper; T Garcez; S Savic; L Savic; E Eren
Journal:  Clin Exp Immunol       Date:  2017-03-13       Impact factor: 4.330

Review 2.  In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.

Authors:  Abdelbaset A Elzagallaai; Michael J Rieder
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

Review 3.  Immunotherapy in allergy and cellular tests: state of art.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin Immunother       Date:  2014-05-02       Impact factor: 3.452

4.  Basophils as a primary inducer of the T helper type 2 immunity in ovalbumin-induced allergic airway inflammation.

Authors:  Wenwei Zhong; Wen Su; Yanjie Zhang; Qi Liu; Jinhong Wu; Caixia Di; Zili Zhang; Zhenwei Xia
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 5.  Basophils and allergic inflammation.

Authors:  Mark C Siracusa; Brian S Kim; Jonathan M Spergel; David Artis
Journal:  J Allergy Clin Immunol       Date:  2013-10       Impact factor: 10.793

6.  Cutaneous Exposure to Clinically Relevant Lone Star Ticks Promotes IgE Production and Hypersensitivity through CD4+ T Cell- and MyD88-Dependent Pathways in Mice.

Authors:  Jessica L Chandrasekhar; Kelly M Cox; William M Loo; Hui Qiao; Kenneth S Tung; Loren D Erickson
Journal:  J Immunol       Date:  2019-07-03       Impact factor: 5.422

Review 7.  Immediate-type hypersensitivity drug reactions.

Authors:  Shelley F Stone; Elizabeth J Phillips; Michael D Wiese; Robert J Heddle; Simon G A Brown
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

Review 8.  Basophils and skin disorders.

Authors:  Francesco Borriello; Francescopaolo Granata; Gianni Marone
Journal:  J Invest Dermatol       Date:  2014-02-06       Impact factor: 8.551

9.  Isolation of Human Basophils.

Authors:  John T Schroeder; Anja P Bieneman
Journal:  Curr Protoc Immunol       Date:  2016-02-02

10.  Sublingual Immunotherapy for Asthma: Affects T-Cells but Does not Impact Basophil Activation.

Authors:  Olga Ciepiela; Anna Zawadzka-Krajewska; Iwona Kotuła; Frans van Overveld; Marek Kulus; Urszula Demkow
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.